Information was received from a patient via a manufacturer representative regarding a patient implanted with a neurostimulator.It was reported that the patient was experiencing pain.Additional information was received from a healthcare professional via a manufacturer representative.It was reported that the patient was reporting intermittent abdominal spasms that occurred a few times a day when the device was on.When the device was turned off, the spasm would go away, but vomiting would return.The patient's device was implanted (b)(6) 2017.In (b)(6) of 2017, settings were 5 milliamperes (ma)/2.5 volts (v) on for 0.1 seconds (s) and off 5 s.It was noted that this was the nominal setting but with increased on/off time.In (b)(6) of 2017, settings were increased to 7.5 ma/3.7 v with increased on time of 0.3 s.In (b)(6) of 2018, settings were increased to 10 ma/5.3 v and increased on time of 1 s.In (b)(6) of 2018, settings were increased to 11.3 ma/6 v with increased on time of 1 s.The patient only reported the spasms to the surgeon in may, but the patient said they started getting spasms in (b)(6), but that over time the spasms had worsened.The patient had the device turned off for a week.Spasms disappeared, but vomiting returned and as a consequence of this, the patient had been remitted to the hospital as the patient's health deteriorated.The manufacturer representative suspected that stimulation was set too high and too long which could be causing the spasms to occur.Impedance values for the system were calculated based on the programming and was within normal range.It was noted that the programming was following the abell algorithm but went a bit higher with the current during the last programming session.
|